Skip to main content Accesibility Help

Cost Comparison of Parenteral Estrogen and Conventional Hormonal Treatment in Patients With Prostatic Cancer

  • Peter Henriksson (a1) and Reinhard Stege (a2)

The present study compares the cost of antitumor therapy and adverse cardiovascular effects during the first year of treatment with oral estrogens, nonoral estrogens, or surgical castration in patients with prostatic cancer. We found a much higher cost for patients treated with orchidectomy and oral estrogens than for patients treated with nonoral estrogens. Twenty-five percent of the patients treated with oral estrogen suffered cardiovascular complications, compared to none of the patients treated by orchidectomy or nonoral estrogens. The initial cost of orchidectomy as compared to nonoral estrogen treatment was shown not to be balanced within the expected survival time of patients with advanced prostatic cancer. Furthermore, surgical castration causes psychological trauma to the patient. We recommend parenteral estrogen therapy as a low-cost therapeutic regimen in patients with prostatic cancer.

Hide All
1.Bailar, S. C., III, & Byar, D. P.Estrogen treatment for cancer of the prostate. Early results with 3 doses of diethylstilbestrol and placebo. Cancer, 1970, 26, 257–61.
2.Damber, M. G., Sandstrom, B., von Schoultz, B., & Stigbrand, T. A.A new and sensitive method for quantifying and comparing the biological potency of various estrogens in man. Acta Obstetrica & Gynecologica Scandinavica, 1979, 58, 527–30.
3.Hedlund, P. O., Gustafsson, H., & Sjögren, S.Cardiovascular complications to treatment of prostate cancer with estramustine phosphate (Estracyt) or conventional estrogen. Scandinavian Journal of Urology and Nephrology, 1980, 55(Suppl.), 103–05.
4.Henriksson, P., Blomback, M., Bratt, G., et al. Activators and inhibitors of coagulation and fibrinolysis in patients with prostatic cancer treated with estrogen or orchidectomy. Thrombosis Research, 1986, 44, 783–91.
5.Henriksson, P., Blombäck, M., Bratt, G., et al. Effects of estrogen therapy and orchidectomy on coagulation and prostanoid synthesis in patients with prostatic cancer. Medical Oncology and Tumor Pharmacotherapy, 1989, 6, 219–25.
6.Henriksson, P., Blombäck, M., Eriksson, A., et al. Effects of parenteral estrogen on the coagulation system in patients with prostatic carcinoma. British Journal of Urology, 1990, 65, 282–85.
7.Henriksson, P., & Edhag, O.Orchidectomy versus estrogen in patients with prostatic cancer: Cardiovascular effects. British Medical Journal, 1986, 293, 513–15.
8.Henriksson, P., & Edhag, O.Cost-effectiveness comparison of estrogen therapy and orchidectomy in patients with prostatic cancer. International Journal of Technology Assessment in Health Care, 1987, 3, 523–29.
9.Henriksson, P., Eriksson, A., Stege, R., et al. Cardiovascular follow-up of patients with prostatic cancer treated with single-drug polyestradiol phosphate. The Prostate, 1988, 13, 257–61.
10.Huggins, C., & Hodges, D. V.Studies on prostatic cancer. I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Research, 1941, 1, 293–97.
11.Huggins, C., Scott, W. W., & Hodges, C. V.Studies on prostatic cancer. III. The effects of fever, of desoxycorticosterone and of estrogen on clinical patients with metastatic carcinoma of the prostate. Journal of Urology, 1941, 46, 9971006.
12.Huggins, C., Stevens, R. E. Jr., & Hodges, C. V.Studies on prostatic cancer. II. The effects of castration in advanced carcinoma of the prostate gland. Archives of Surgery, 1941, 43, 209–23.
13.Stege, R., Carlstrom, K., Collste, L., et al. Single-drug parenteral estrogen treatment in prostatic cancer: A study of two maintenance-dose regimens. The Prostate, 1989, 14, 183–88.
14.Veterans Administration's Cooperative Urological Research Group. Carcinoma of the prostate: Treatment comparison. Journal of Urology, 1967, 98, 516–22.
15.von Schoultz, B., Carlstrom, K., Collste, L., et al. Estrogen therapy and liver function — metabolic effects of oral and parenteral administration. The Prostate, 1989, 14, 389–95.
16.Weinstein, M. C., & Stason, W. B.Foundations of cost-effectiveness analysis for health and medical practices. New England Journal of Medicine, 1977, 296, 716–21.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

International Journal of Technology Assessment in Health Care
  • ISSN: 0266-4623
  • EISSN: 1471-6348
  • URL: /core/journals/international-journal-of-technology-assessment-in-health-care
Please enter your name
Please enter a valid email address
Who would you like to send this to? *


Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed